Policy Statements

Patient re-contact after revision of genomic test results: Points-to-Consider

ACMG Statement Insuring Patient Access and Affordability for Treatments

Professional responsibilities regarding the provision,publication, and dissemination of patient phenotypes in the context of clinical genetic and genomic testing: points to consider -- a statement of the ACMG

Professional responsibilities regarding the provision,publication, and dissemination of patient phen

Considerations in healthcare reform for patients and families with genetic diseases: a statement of the American College of Medical Genetics and Genomics

Considerations in healthcare reform for patients and families with genetic diseases: a statement of

Laboratory and clinical genomic data sharing is crucial to improving genetic health care: a position statement of the American College of Medical Genetics and Genomics

Laboratory and clinical genomic data sharing is crucial to improving genetic health care: a position

Genome editing in clinical genetics: points to consider -- a statement of the American Medical Genetics and Genomics

Genome editing in clinical genetics: points to consider -- a statement of the American Medical Genet

ACMG Statement on Diversity and Inclusivity

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 up

Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics

Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the Americ

ACMG Revised Position Statement on Direct-to-Consumer Genetic Testing

Clinical utility of genetic and genomic services: a position statement of the American College of Medical Genetics and Genomics

Clinical utility of genetic and genomic services: a position statement of the American College of Me

Scope of practice: a statement of the American College of Medical Genetics and Genomics (ACMG)

ACMG Recommendations for reporting of incidental findings in clinical exome and genome sequencing

ACMG Statement on Access to Reproductive Options After Prenatal Diagnosis

Technical report: ethical and policy issues in genetic testing and screening of children

Incidental Findings in Clinical Genomics: A Clarification

Points to Consider for Informed Consent for Genome/Exome Sequencing

ACMG position statement on prenatal/ preconception expanded carrier screening

Points to Consider in the Clinical Application of Genomic Sequencing

American College of Medical Genetics and Genomics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants

American College of Medical Genetics and Genomics standards and guidelines for interpretation and re

Folic Acid and Neutral Tube Defects

Position Statement on Importance of Residual Newborn Screening Dried Blood Spots

Conflict of Interest

Emergency Preparedness for Newborn Screening and Genetic Services

Pharmacogenetic Testing of CYP2C9 and VKORC1alleles for Warfarin

A Rapid ACCE1 Review of CYP2C9 and VKORC1 Allele Testing to Inform Warfarin Dosing in Adults at Elevated Risk for Thrombotic Events to Avoid Serious Bleeding

A Rapid ACCE1 Review of CYP2C9 and VKORC1 Allele Testingto Inform Warfarin Dosing in Adults at Elev

Newborn Screening: Toward a Uniform Screening Panel and System

Position Statement on Gene Patents & Accessibility of Gene Testing

Statement on Universal Newborn Hearing Screening

Genetics and Managed Care

Points to Consider in Preventing Unfair Discrimination Based on Genetic Disease Risk: A Position Statement of the American College of Medical Genetics and Genomics

Points to Consider in Preventing Unfair Discrimination Based on Genetic Disease Risk: A Position Sta

Laboratory Standards and Guidelines for Population Based Cystic Fibrosis Carrier Screening

Guidelines for Expert Witness Testimony for the Specialty of Medical Genetics

Genetic Testing in Adoption (ACMG/ASHG)

Tandem Mass Spectrometry in Newborn Screening

FISH2: FISH Technical and Clinical Assessment of: An ACMG/ASHG Position Statement. I: Technical Considerations

FISH2: FISH Technical and Clinical Assessment of: An ACMG/ASHG Position Statement. I: Technical Cons

Duty to Re-Contact

Statement on Nutritional Supplements & Piracetam for Children with Down Syndrome

Statement on Storage & Use of Genetic Materials

Consensus Statement on Use of Apolipoprotein E Testing for Alzheimer Disease